EPI-743 for Metabolism or Mitochondrial Disorders

NCT01642056 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Mitochondrial Disease
Neurology
Myopathy

Interventions

DRUG: EPI-743
DRUG: Placebo

Sponsor

National Human Genome Research Institute (NHGRI)